Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
DOI:
https://doi.org/10.6000/1929-2279.2018.07.03.3Keywords:
Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.Abstract
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
References
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Ciro Comparetto, Franco Borruto, Molecular Technologies in Gynecologic Oncology , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Karina Torres Mojica, Jorge R. Miranda Massari, Jose R. Rodriguez, Jose Olalde, Miguel Berdiel, Michael J. Gonzalez, Structured Water and Cancer: Orthomolecular Hydration Therapy , Journal of Cancer Research Updates: Vol. 12 (2023)
- Hassan Bahrami, Majid Tafrihi, Understanding the Warburg Effect Yields New Insights into the Metabolic Control of Cancer , Journal of Cancer Research Updates: Vol. 12 (2023)
- Sandip K. Mishra, K. Kanchan, Dharmendra K. Bhargava, A Review on EZH2 and its Epigenetic Association with Breast Cancer , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Rajesh K. Sain, Raje Chouhan, Laxmi P. Bagri, A.K. Bajpa, Strategies of Targeting Tumors and Cancers , Journal of Cancer Research Updates: Vol. 1 No. 1 (2012)
- Pravin K. Naoghare, Ajam Shekh, Amit Bafana, Kannan Krishnamurthi, Saravanadevi Sivanesan, Unveiling the Unpredicted and Uncontrolled Metastasis of Cancer Cells: A Minireview , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Ricardo Hsieh, The Role of BRAF Gene in Cancer: Literature Review and Future Directions , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Sisir Nandi, Manish C. Bagchi, EGFr, FGFr and PDGFr: Emerging Targets for Anticancer Drug Design , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
- Peng-Wei Zhang, Zhe-Sheng Chen, Zhi Shi, Targeting Snail1 by CRISPR/Cas9 System Inhibits the Proliferation and Migration of Human Gastric Cancer Cells , Journal of Cancer Research Updates: Vol. 12 (2023)
- Fei Zhou, Lothar Esser, Di Xia, Recent Advances in Understanding the Structure and Function Relationship of Multidrug Resistance-Linked ABC Transporter P-glycoprotein , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
You may also start an advanced similarity search for this article.